News and Announcements
4Dx Closes $500k Retail Funding Round to Add to $4M in Wholesale Capital
- Published September 13, 2016 9:26AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Innovative med-tech company 4Dx is a step closer to commercialising its four-dimensional lung imaging technology after successfully closing a $500,000 retail raise fully subscribed. This comes in addition to the company already raising AU$4m in capital from private investors which will be used to advance the business beyond initial FDA clearance early next year.
4Dx’s lung imaging technology has the potential to play a major role in the diagnostics and treatment of respiratory diseases such as asthma, chronic obstructive pulmonary disease, cystic fibrosis and lung cancer.
The close of the retail round brings the total funds invested in this technology to Over $15million which includes backing by 4Dx investors, grants and R&D tax incentives and US$600k from the sales of a pre-clinical scanner to a major U.S Hospital.